Roman-Blas JA - Search Results

1

Osteoarthritis associated with estrogen deficiency.

Roman-Blas JA, Castañeda S, Largo R, Herrero-Beaumont G. Roman-Blas JA, et al. Arthritis Res Ther. 2009;11(5):241. doi: 10.1186/ar2791. Epub 2009 Sep 21. Arthritis Res Ther. 2009. PMID: 19804619 Free PMC article. Review.

2

Primary osteoarthritis no longer primary: three subsets with distinct etiological, clinical, and therapeutic characteristics.

Herrero-Beaumont G, Roman-Blas JA, Castañeda S, Jimenez SA. Herrero-Beaumont G, et al. Semin Arthritis Rheum. 2009 Oct;39(2):71-80. doi: 10.1016/j.semarthrit.2009.03.006. Epub 2009 Jul 9. Semin Arthritis Rheum. 2009. PMID: 19589561 Review.

3

Efficacy and safety of a selective estrogen receptor β agonist, ERB-041, in patients with rheumatoid arthritis: a 12-week, randomized, placebo-controlled, phase II study.

Roman-Blas JA, Castañeda S, Cutolo M, Herrero-Beaumont G. Roman-Blas JA, et al. Arthritis Care Res (Hoboken). 2010 Nov;62(11):1588-93. doi: 10.1002/acr.20275. Epub 2010 Jun 15. Arthritis Care Res (Hoboken). 2010. PMID: 20556817 Free article. Clinical Trial.

4

Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis.

Bellido M, Lugo L, Roman-Blas JA, Castañeda S, Caeiro JR, Dapia S, Calvo E, Largo R, Herrero-Beaumont G. Bellido M, et al. Arthritis Res Ther. 2010;12(4):R152. doi: 10.1186/ar3103. Epub 2010 Aug 2. Arthritis Res Ther. 2010. PMID: 20678201 Free PMC article.

5

Bone mineral density and joint cartilage: four clinical settings of a complex relationship in osteoarthritis.

Herrero-Beaumont G, Roman-Blas JA, Largo R, Berenbaum F, Castañeda S. Herrero-Beaumont G, et al. Ann Rheum Dis. 2011 Sep;70(9):1523-5. doi: 10.1136/ard.2011.151233. Epub 2011 Jul 7. Ann Rheum Dis. 2011. PMID: 21742638

6

Subchondral bone as a key target for osteoarthritis treatment.

Castañeda S, Roman-Blas JA, Largo R, Herrero-Beaumont G. Castañeda S, et al. Biochem Pharmacol. 2012 Feb 1;83(3):315-23. doi: 10.1016/j.bcp.2011.09.018. Epub 2011 Sep 22. Biochem Pharmacol. 2012. PMID: 21964345 Review.

7

RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis.

Martínez-Calatrava MJ, Prieto-Potín I, Roman-Blas JA, Tardio L, Largo R, Herrero-Beaumont G. Martínez-Calatrava MJ, et al. Arthritis Res Ther. 2012 Jun 18;14(3):R149. doi: 10.1186/ar3884. Arthritis Res Ther. 2012. PMID: 22709525 Free PMC article.

8

Targeting subchondral bone in osteoporotic osteoarthritis.

Roman-Blas JA, Herrero-Beaumont G. Roman-Blas JA, et al. Arthritis Res Ther. 2014 Nov 25;16(6):494. doi: 10.1186/s13075-014-0494-0. Arthritis Res Ther. 2014. PMID: 25664969 Free PMC article.

9

Selective estrogen receptor modulators (SERMs): new alternatives for osteoarthritis?

Lugo L, Villalvilla A, Largo R, Herrero-Beaumont G, Roman-Blas JA. Lugo L, et al. Maturitas. 2014 Apr;77(4):380-4. doi: 10.1016/j.maturitas.2014.01.016. Epub 2014 Feb 15. Maturitas. 2014. PMID: 24602552 Review.

10

Differential effects of the antioxidant n-acetylcysteine on the production of catabolic mediators in IL-1beta-stimulated human osteoarthritic synoviocytes and chondrocytes.

Roman-Blas JA, Contreras-Blasco MA, Largo R, Alvarez-Soria MA, Castañeda S, Herrero-Beaumont G. Roman-Blas JA, et al. Eur J Pharmacol. 2009 Nov 25;623(1-3):125-31. doi: 10.1016/j.ejphar.2009.09.016. Epub 2009 Sep 16. Eur J Pharmacol. 2009. PMID: 19765584

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters